Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the FDA's selection of seven companies for its ...
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the FDA's push to innovate, what to expect under new ...
Senior Fellow Scott Gottlieb discusses GLP-1’s and the drug approval process: Gottlieb on CNBC’s “Squawk Box.” ...
Senior Fellow Scott Gottlieb discusses the FDA’s new rare disease framework on CNBC’s ‘Squawk Box.’ ...
Senior Fellow Scott Gottlieb discusses possible updates to the childhood vaccine schedule and new drug pricing proposals on CNBC’s ‘Squawk Box.’ ...
Senior Fellow Scott Gottlieb discusses the rapid expansion of CAR-T therapies, the implications of the new Psychedelics Executive Order, and efforts to streamline FDA approvals for next-gen treatments ...
Senior Fellow Scott Gottlieb discusses the latest on the hantavirus outbreak, developments at the FDA, and the agency’s updated policies on vaping devices on CNBC’s ‘Squawk Box.’ ...
CNBC’s “Squawk Box” team discusses the Washington Post's reporting that the Trump administration is planning to tie Tylenol use during pregnancy to the risk of Autism with Dr. Scott Gottlieb, CNBC ...
Senior Fellow Scott Gottlieb discusses the latest developments in the Ebola outbreak in West Africa and FDA management changes on CNBC’s ‘Squawk Box.’ ...